Network pharmacology-based study of the molecular mechanisms of Qixuekang in treating COVID-19 during the recovery period
Authors:
- 1 January 2020
- journal article
- research article
- Vol. 13 (10) , 2677-2690
Abstract
Objective: In this research, the analytical method of network pharmacology was used to explore Qixuekang molecular mechanism in treating Coronavirus 2019 (COVID-19) during the recovery period. Methods: Traditional Chinese Medicine Systems Pharmacology (TCMSP) database was used to collect the active components and corresponding targets of Qixuekang. Disease targets, related to COVID-19 during the recovery period, were collected from the GeneCards database. Protein-Protein interaction (PPI) network was built by usingthe String database, and analyzing and using Cytoscape 3.7.0 software to screen out hub genes. GO enrichment and KEGG pathway enrichment analysis were analyzed by R 3.6.1 software. Results: 34 active components of Qixuekang were screened out, and 161 common targets of drug and disease were identified. GO enrichment suggested 141 biologic processes, mainly involving nuclear receptor activity, transcription factor activity, and direct ligand regulated sequence-specific DNA binding. KEGG pathway enrichment suggests 96 signaling pathways, mainly including TNF signaling pathway, IL-17 signal pathway, and C-type lectin receptor signal pathway. The hub genes, screened in the PPI network, were mainly inclusive of CXCL8, CXCL2, CXCL10, ADRA2A, and ADRA2C. Conclusion: Qixuekang has numerous components and targets in treating COVID-19 during the recovery period. It is mainly applied in anti-inflammatory action and regulating immune defense, which may guide clinical trials in the later stage.Keywords
This publication has 20 references indexed in Scilit:
- Genetic Polymorphism of CHRM2 in COPD: Clinical Significance and Therapeutic ImplicationsJournal of Cellular Physiology, 2015
- Isorhamnetin augments the anti-tumor effect of capeciatbine through the negative regulation of NF-κB signaling cascade in gastric cancerCancer Letters, 2015
- Protective effects of isorhamnetin on apoptosis and inflammation in TNF-α-induced HUVECs injury.2015
- Ethyl linoleate from garlic attenuates lipopolysaccharide-induced pro-inflammatory cytokine production by inducing heme oxygenase-1 in RAW264.7 cellsInternational Immunopharmacology, 2014
- O-methylated flavonol isorhamnetin prevents acute inflammation through blocking of NF-κB activationFood and Chemical Toxicology, 2013
- Anti-inflammatory effects of β-sitosterol-β-D-glucoside fromTrachelospermum jasminoides(Apocynaceae) in lipopolysaccharide-stimulated RAW 264.7 murine macrophagesNatural Product Research, 2012
- In Vivo and in Vitro Antiviral Activities of Calycosin-7-O-.BETA.-D-glucopyranoside against Coxsackie Virus B3Biological and Pharmaceutical Bulletin, 2009
- Isorhamnetin prevent endothelial cell injuries from oxidized LDL via activation of p38MAPKEuropean Journal of Pharmacology, 2006
- Isorhamnetin glycosides with free radical and ONOO− scavenging activities from the stamens ofNelumbo nuciferaArchives of Pharmacal Research, 2006
- [The role of Toll-like receptors (TLR) in innate and adaptive immune responses and their function in immune response regulation].2006